BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36202277)

  • 21. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma.
    Lin J; Xu N; An W
    J Coll Physicians Surg Pak; 2024 Mar; 34(3):290-295. PubMed ID: 38462863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
    Wu X; Wang S; Wang C; Wu C; Zhao Z
    Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].
    Wang Y; Wang YS; Hu NB; Teng GS; Zhou Y; Bai J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):804-812. PubMed ID: 35680809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of potential hub genes of gastric cancer.
    Zhou XD; Qu YW; Wang L; Jia FH; Chen P; Wang YP; Liu HF
    Medicine (Baltimore); 2022 Oct; 101(41):e30741. PubMed ID: 36254003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
    Yang J
    Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRANSCRIPTOME ANALYSIS REVEALED THE MOLECULAR SIGNATURES OF CISPLATIN-FLUOROURACIL COMBINED CHEMOTHERAPY RESISTANCE IN GASTRIC CANCER.
    Luo Y; Chen X; Hu E; Wang L; Yang Y; Jiang X; Zheng K; Wang L; Li J; Xu Y; Wang Y; Xie Y
    Georgian Med News; 2023 Dec; (345):6-18. PubMed ID: 38325291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of the pathogenesis of Sjögren's syndrome via DNA methylation and transcriptome analyses.
    Du Y; Li J; Wu J; Zeng F; He C
    Clin Rheumatol; 2022 Sep; 41(9):2765-2777. PubMed ID: 35562622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population.
    Xie Y; Wu H; Hu W; Zhang H; Li A; Zhang Z; Ren S; Zhang X
    Pathol Oncol Res; 2022; 28():1610455. PubMed ID: 36032660
    [No Abstract]   [Full Text] [Related]  

  • 38. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
    Sadegh K; Ahmadi A
    IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.